Multiscreen (HIV test, hepatitis and syphilis)

2021: Launch of production of the world's first combined tests for HIV, hepatitis and syphilis in the Russian Federation

At the end of April 2021 Russia , production began on the world's first combined test for four infections:, and HIV. hepatitis types B and C syphilis Test systems called "Multiscreen" are produced by the company "," Biopalette which is a resident of the special economic zone. "St. Petersburg

One Multiscreen kit includes components for 96 tests. The result of the study can be obtained in 1 hour 55 minutes, which is three times faster than a separate diagnosis for each infection.

The planned capacity of launched production is 5.76 million tests per year. The company sent the first experimental batch of products to the federal network of clinical and diagnostic laboratories. " Citilab Among other future clients are large clinics, transfusion stations, blood diagnostic centers. The volume of investments in the serial production of technology amounted to about 130 million. rubles

The product passed clinical trials on the basis of the Novosibirsk Research Institute "Vector" Rospotrebnadzor and received a registration certificate. In addition, the development passed additional tests on the basis of the Moscow Research Institute of Ambulance named after N.V. Sklifosovsky. Studies confirmed specificity and sensitivity at a high level.

The company believes that the use of combined test systems will reach more people, as well as triple the number of manipulations, man-hours and plastic waste in laboratories

According to Nikolai Maksimov, co-founder of Biopalitra, around 2022 the company plans to start releasing a "complete multiplex" with all markers and confirming tests. This product will not only reveal a positive result for AIDS, hepatitis and syphilis, but also get an answer for which of the infections it is positive.^[1]

Notes